A robust circular RNA-based prognostic signature for postoperative recurrence in stage II/III colon cancer

被引：2
|
作者：
Ruan, Ji [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Peoples R China
来源：
AIMS GENETICS | 2019年 / 6卷 / 04期
关键词：
D O I：
10.3934/genet.2019.4.67
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：67 / 69
页数：3
相关论文
共 50 条
  • [21] CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer
    Dalerba, Piero
    Sahoo, Debashis
    Paik, Soonmyung
    Guo, Xiangqian
    Yothers, Greg
    Song, Nan
    Wilcox-Fogel, Nate
    Forgo, Erna
    Rajendran, Pradeep S.
    Miranda, Stephen P.
    Hisamori, Shigeo
    Hutchison, Jacqueline
    Kalisky, Tomer
    Qian, Dalong
    Wolmark, Norman
    Fisher, George A.
    van de Rijn, Matt
    Clarke, Michael F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 211 - 222
  • [22] Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer
    Belt, Eric J. Th
    Brosens, Rebecca P. M.
    Delis-van Diemen, Pien M.
    Bril, Herman
    Tijssen, Marianne
    van Essen, Dirk F.
    Heymans, Martijn W.
    Belien, Jeroen A. M.
    Stockmann, Hein B. A. C.
    Meijer, Sybren
    Meijer, Gerrit A.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S682 - S692
  • [23] Predictors of recurrence free survival for patients with stage II and III colon cancer
    Vassiliki L Tsikitis
    David W Larson
    Marianne Huebner
    Christine M Lohse
    Patricia A Thompson
    BMC Cancer, 14
  • [24] Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer
    Eric J. Th. Belt
    Rebecca P. M. Brosens
    Pien M. Delis-van Diemen
    Herman Bril
    Marianne Tijssen
    Dirk F. van Essen
    Martijn W. Heymans
    Jeroen A. M. Beliën
    Hein B. A. C. Stockmann
    Sybren Meijer
    Gerrit A. Meijer
    Annals of Surgical Oncology, 2012, 19 : 682 - 692
  • [25] Predictors of recurrence free survival for patients with stage II and III colon cancer
    Tsikitis, Vassiliki L.
    Larson, David W.
    Huebner, Marianne
    Lohse, Christine M.
    Thompson, Patricia A.
    BMC CANCER, 2014, 14
  • [26] Clinical score to predict recurrence in patients with stage II and III colon cancer
    Vinal, D.
    Martinez-Recio, S.
    Martinez Perez, D.
    Jimenez-Bou, D.
    Ruiz, I.
    Pena, J.
    Martin-Montalvo, G.
    Alameda, M.
    Rueda-Lara, A.
    Gutierrez-Sainz, L.
    Palacios, M.
    Custodio, A.
    Ghanem, I.
    Feliu, J.
    Rodriguez-Salas, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S279 - S279
  • [27] Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
    Lurje, Georg
    Zhang, Wu
    Yang, Dongyun
    Groshen, Susan
    Hendifar, Andrew E.
    Husain, Hatim
    Nagashima, Fumio
    Chang, Heung M.
    Fazzone, William
    Ladner, Robert D.
    Pohl, Alexandra
    Ning, Yan
    Iqbal, Syma
    El-Khoueiry, Anthony
    Lenz, Heinz-Josef
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (02): : 161 - 168
  • [28] Loss of Bcl-2 expression in colon cancer: A prognostic factor for recurrence in stage II colon cancer
    Poincloux, Laurent
    Durando, Xavier
    Seitz, Jean Francois
    Thivat, Emilie
    Bardou, Valerie-Jeanne
    Giovannini, Marie-Helene
    Parriaux, Daniele
    Barriere, Nicolas
    Giovannini, Marc
    Delpero, Jean-Robert
    Monges, Genevieve
    SURGICAL ONCOLOGY-OXFORD, 2009, 18 (04): : 357 - 365
  • [29] Utility of Postoperative Circulating Tumor DNA (ctDNA) as a Prognostic Marker of Disease Recurrence in Stage II/III Colon Cancer: A Systematic Review and Meta-Analysis
    Alqahtani, Ali
    Ghazaleh, Sami
    Albalawy, Rakan
    Abdulsattar, Waleed
    Cook, Michael
    Lee-Smith, Wade
    Aziz, Muhammad
    Alhallak, Mohammed Najeeb
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S163 - S163
  • [30] Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer
    Liming Wang
    Yasumitsu Hirano
    Toshimasa Ishii
    Hiroka Kondo
    Kiyoka Hara
    Nao Obara
    Shigeki Yamaguchi
    World Journal of Surgical Oncology, 18
12345